| (P125) |
Co-expression of αIIbβ3 and αvβ3 integrins in human melanoma upregulates bFGF expression and promotes tumor-induced angiogenesis. |
|
B. Dome, E. Raso, J. Dobos, L. Meszaros, N. Varga, L.G. Puskas, L.Z. Feher, T. Lorincz, A. Ladanyi, K.V. Honn, J. Timar (Budapest and Szeged, HU; Detroit, US) |
| (P126) |
Expression and function of EphB4 in tumor cells. |
|
K. Emmerich, D. Zopf, for CRBA Experimental Oncology (Berlin, DE) |
| (P127) |
Long-term observation reveals time course dependent functional and morphological characteristics of tumorvascularization. |
|
C. Joscheck, Chr. Schaefer, K. Lamszus, L. Wolfram, T. Biermann, P. Algenstaedt, C. Heintz, W. Fiedler, W. Rüther, N. Hansen-Algenstaedt (Hamburg, DE) |
| (P128) |
Characterization of functional and morphological properties of microcirculation in leukemic tumors in vivo. |
|
M. Schroeder, Chr. Schaefer, C. Joscheck, W. Fiedler, W. Rüther, N. Hansen-Algenstaedt (Hamburg, DE) |
| (P129) |
Identification and characterization of activated aortic valve cells with high angiogenic potential. |
|
F. Chalajour, H. Treede, U.M. Gehling, A. Ebrahimnejad, D.H. Boehm, S. Ergün, H. Reichenspurner, on behalf of University Heart Center Research Group (Hamburg, DE) |
| (P130) |
Human HIF-3α is a novel inhibitor of angiogenesis. |
|
S. Bonello, A. Petry, R.S. Belaiba, Chr. Zähringer, T. Djordjevic, J. Hess, A. Görlach (München, DE) |
| (P131) |
Cytochrome P450 epoxygenases 2C8/9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. |
|
R. Michaelis, B. Fisslthaler, E. Barbosa-Sicard, J.R. Falck, I. Fleming, R. Busse (Frankfurt/Main, DE; Dallas, US) |
| (P132) |
Homeobox A9 regulates the angiogenic function of endothelial cells and endothelial progenitor cells: role of integrin expression. |
|
C. Urbich, T. Brühl, A.M. Zeiher, S. Dimmeler (Frankfurt/Main, DE) |
| (P133) |
Epoxyeicosatrienoic acids act as second messengers in VEGF-induced angiogenesis. |
|
R. Michaelis, B. Fisslthaler, J.R. Falck, I. Fleming, R. Busse (Frankfurt/Main, DE; Dallas, US) |
| (P134) |
Angio- and vasculogenic function of erythropoietin. |
|
A. Schmidt, J. Müller-Ehmsen, B. Krausgrill, R.H.G. Schwinger, W. Bloch (Cologne, DE) |
| (P135) |
Atypical GPI-anchored T-cadherin stimulates angiogenesis in vitro. |
|
M. Philippova, D. Ivanov, R. Allenspach, P. Erne, T. Resink (Basel and Lucern, CH) |
| (P136) |
CD40 stimulation inhibits VEGF induced endothelial cell migration. |
|
U. Thanabalasingam, D. Stibenz, S. Goetze, Ph. Stawowy, M. Roser, H. Kallisch, K. Graf, E. Fleck, M. Gräfe (Berlin, DE) |
| (P137) |
Melatonin is an inhibitor of vascular cell proliferation in vitro. |
|
S. Gendreau, V. Tchaikovski, J. Waltenberger (Maastricht, NL) |
| (P138) |
Endostatin altered endothelial cells in different ways. |
|
A. Schmidt, W. Bloch (Cologne, DE) |
| (P139) |
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells. |
|
M. Michaelis, U.R. Michaelis, F. Rothweiler, D. Eikel, M. Zörnig, H. Nau, I. Fleming, H.W. Doerr, J. Cinatl jr. (Frankfurt/Main and Hannover, DE) |
| (P140) |
Sphingosine-1-phosphate receptor S1P1 is a key regulator of endothelial cell function. |
|
V. Krump-Konvalinkova, S. Yasuda, T. Rubic, W. Erl, C. Vosseler, C.J. Kirkpatrick, G. Tigyi, W. Siess (Munich and Mainz, DE; Memphis, US) |